Literature DB >> 7906409

c-erbA alpha/T3R and RARs control commitment of hematopoietic self-renewing progenitor cells to apoptosis or differentiation and are antagonized by the v-erbA oncogene.

O Gandrillon1, N Ferrand, J J Michaille, L Roze, M H Zile, J Samarut.   

Abstract

In AEV-transformed erythroleukemic cells the v-erbA gene product is likely to antagonize the function of triiodothyronine (T3) and retinoic acid (RA) receptors and thereby to block cell differentiation. We have thus investigated the effects of T3 and RA on normal early erythrocytic progenitor cells. Here we show: (1) that either RA or T3 play an essential role during the early commitment to erythrocytic differentiation, (2) that both T3 and RA induce death by apoptosis and a strong inhibition of self-renewal in progenitor cells grown in the absence of differentiation-inducing agents and (3) that the v-erbA oncogene renders erythrocytic progenitor cells insensitive to apoptosis and to self-renewal inhibition induced by RA or T3. The behaviour of a non-transforming mutant of v-erbA suggests that this v-erbA-induced protection is related to its transforming potential.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906409

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  Cholesterol synthesis-related enzyme oxidosqualene cyclase is required to maintain self-renewal in primary erythroid progenitors.

Authors:  C Mejia-Pous; F Damiola; O Gandrillon
Journal:  Cell Prolif       Date:  2011-10       Impact factor: 6.831

2.  The T3R alpha gene encoding a thyroid hormone receptor is essential for post-natal development and thyroid hormone production.

Authors:  A Fraichard; O Chassande; M Plateroti; J P Roux; J Trouillas; C Dehay; C Legrand; K Gauthier; M Kedinger; L Malaval; B Rousset; J Samarut
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

3.  Multiple mutations contribute to repression by the v-Erb A oncoprotein.

Authors:  Sangho Lee; Martin L Privalsky
Journal:  Oncogene       Date:  2005-10-13       Impact factor: 9.867

4.  Regulation of microglial development: a novel role for thyroid hormone.

Authors:  F R Lima; A Gervais; C Colin; M Izembart; V M Neto; M Mallat
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

5.  Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.

Authors:  A Rascle; N Ferrand; O Gandrillon; J Samarut
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

6.  Reciprocal interplay between thyroid hormone and microRNA-21 regulates hedgehog pathway-driven skin tumorigenesis.

Authors:  Daniela Di Girolamo; Raffaele Ambrosio; Maria A De Stefano; Giuseppina Mancino; Tommaso Porcelli; Cristina Luongo; Emery Di Cicco; Giulia Scalia; Luigi Del Vecchio; Annamaria Colao; Andrzej A Dlugosz; Caterina Missero; Domenico Salvatore; Monica Dentice
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

7.  The transcriptional program of a human B cell line in response to Myc.

Authors:  M Schuhmacher; F Kohlhuber; M Hölzel; C Kaiser; H Burtscher; M Jarsch; G W Bornkamm; G Laux; A Polack; U H Weidle; D Eick
Journal:  Nucleic Acids Res       Date:  2001-01-15       Impact factor: 16.971

8.  TGF-beta cooperates with TGF-alpha to induce the self-renewal of normal erythrocytic progenitors: evidence for an autocrine mechanism.

Authors:  O Gandrillon; U Schmidt; H Beug; J Samarut
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

9.  The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.

Authors:  A Bauer; W Mikulits; G Lagger; G Stengl; G Brosch; H Beug
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

10.  Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.

Authors:  P Ciana; G G Braliou; F G Demay; M von Lindern; D Barettino; H Beug; H G Stunnenberg
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.